Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02416518 · ClinicalTrials.gov registry record
Genetic Exploration of the Molecular Basis of Malignancy in Adults
A clinical trial of Neoplasms, sponsored by Sanford Health.
- Completed
- Registry status
- 120
- Enrollment target
- 4
- Study locations
NCT02416518 is a study of Neoplasms that has completed, run by Sanford Health. The registered enrollment target is 120 participants, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (93% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT02416518, a study of Neoplasms, has completed, sponsored by Sanford Health.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
- 4
- Study locations
Study Summary
Genetic Exploration of the Molecular Basis of Malignancy in Adults.
Conditions Studied
Study Locations (4)
North Dakota
- Sanford Health - Bismarck
- Sanford Health - Fargo
Minnesota
- Sanford Health - Bemidji
South Dakota
- Sanford Health - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02416518
The ClinicalTrials.gov registry entry for NCT02416518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,621-participant average among 158 other Neoplasms trials with a reported enrollment target (93% lower). The listed sponsor is Sanford Health, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT02416518 reports 4 study locations spanning 3 distinct geographic areas - top geographies include North Dakota, Minnesota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT02416518 about?
NCT02416518 is a clinical study titled "Genetic Exploration of the Molecular Basis of Malignancy in Adults". Genetic Exploration of the Molecular Basis of Malignancy in Adults.
What is the current status of trial NCT02416518?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2014-05. Estimated completion is 2018-12.
What conditions does trial NCT02416518 study?
This clinical trial studies the following conditions: Neoplasms.
Who is sponsoring clinical trial NCT02416518?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02416518 being conducted?
This trial has 4 study locations across Minnesota, North Dakota, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
RECRUITING · Phase 1
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
RECRUITING · Phase 1
-
Endometrial Cell Collection With the PadKit
RECRUITING · NA
-
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study
RECRUITING · Phase 1
-
Resilience in East Asian Immigrants for Advance Care Planning Discussions
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.